Q2 2022 Mirum Pharmaceuticals Inc Earnings Call Transcript
Good afternoon. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Mirum Q2 2022 Business Update. (Operator Instructions)
Ian Clements, Chief Financial Officer. You may begin.
Thanks, Chris, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals Second Quarter 2022 Conference Call. I'm joined today by our President and CEO, Chris Peetz; our Chief Operating Officer, Peter Radovich; and our Head of R&D, Pam Vig.
Earlier this afternoon, Mirum issued a news release announcing the company's results for the second quarter of 2022. Copies of this news release from SEC filings can be found in the Investors section of our website.
Before we begin, I would like to remind you that during the course of this conference call, we will be making certain forward-looking statements about Mirum and our programs based on management's current expectations, including statements regarding Mirum's business plans,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |